IDH1 and acute myeloid leukemia: Isocitrate dehydrogenase type 1 (IDH1) mutation has been observed in 6–16% of adult patients with AML and is frequently associated with NPM1, DNTM3A, and FLT3-ITD mutations, an association that leads to inferior outcome [65].